BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19556095)

  • 1. Impact of Access to Recovery services on alcohol/drug treatment outcomes.
    Krupski A; Campbell K; Joesch JM; Lucenko BA; Roy-Byrne P
    J Subst Abuse Treat; 2009 Dec; 37(4):435-42. PubMed ID: 19556095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Washington State Access to Recovery project: effects on Medicaid costs for working age disabled clients.
    Wickizer TM; Mancuso D; Campbell K; Lucenko B
    J Subst Abuse Treat; 2009 Oct; 37(3):240-6. PubMed ID: 19339138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of brief interventions and brief treatment on admissions to chemical dependency treatment.
    Krupski A; Sears JM; Joesch JM; Estee S; He L; Dunn C; Huber A; Roy-Byrne P; Ries R
    Drug Alcohol Depend; 2010 Jul; 110(1-2):126-36. PubMed ID: 20347234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient satisfaction, use of services, and one-year outcomes in publicly funded substance abuse treatment.
    Carlson MJ; Gabriel RM
    Psychiatr Serv; 2001 Sep; 52(9):1230-6. PubMed ID: 11533398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of full vs. partial continuum of care in the treatment of publicly funded substance abusers in Washington State.
    McKay JR; Donovan DM; McLellan T; Krupski A; Hansten M; Stark KD; Geary K; Cecere J
    Am J Drug Alcohol Abuse; 2002; 28(2):307-38. PubMed ID: 12014818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting readmission to substance abuse treatment using state information systems. The impact of client and treatment characteristics.
    Luchansky B; He L; Krupski A; Stark KD
    J Subst Abuse; 2000; 12(3):255-70. PubMed ID: 11367603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of medical conditions and primary care services in 5-year substance use outcomes among chemical dependency treatment patients.
    Mertens JR; Flisher AJ; Satre DD; Weisner CM
    Drug Alcohol Depend; 2008 Nov; 98(1-2):45-53. PubMed ID: 18571875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of managed care on publicly funded outpatient adolescent substance abuse treatment: service use and six-month outcomes in Oregon and Washington.
    Carlson MJ; Gabriel RM; Deck DD; Laws KE; D'Ambrosio R
    Med Care Res Rev; 2005 Jun; 62(3):320-38. PubMed ID: 15894707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Access to Recovery and Recidivism Among Former Prison Inmates.
    Ray B; Grommon E; Buchanan V; Brown B; Watson DP
    Int J Offender Ther Comp Criminol; 2017 Jun; 61(8):874-893. PubMed ID: 26385191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing access and providing social services to improve drug abuse treatment for women with children.
    Marsh JC; D'Aunno TA; Smith BD
    Addiction; 2000 Aug; 95(8):1237-47. PubMed ID: 11092071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Social support and cognitive impairment in clients receiving treatment for alcohol- and drug-use disorders: a replication study.
    Buckman JF; Bates ME; Morgenstern J
    J Stud Alcohol Drugs; 2008 Sep; 69(5):738-46. PubMed ID: 18781249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment readmissions and criminal recidivism in youth following participation in chemical dependency treatment.
    Luchansky B; He L; Longhi D; Krupski A; Stark KD
    J Addict Dis; 2006; 25(1):87-94. PubMed ID: 16597576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of substance abuse treatment on arrests among opiate users in Washington State.
    Campbell KM; Deck D; Krupski A
    Am J Addict; 2007; 16(6):510-20. PubMed ID: 18058419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retention, early dropout and treatment completion among therapeutic community admissions.
    Darke S; Campbell G; Popple G
    Drug Alcohol Rev; 2012 Jan; 31(1):64-71. PubMed ID: 21426420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distance traveled to outpatient drug treatment and client retention.
    Beardsley K; Wish ED; Fitzelle DB; O'Grady K; Arria AM
    J Subst Abuse Treat; 2003 Dec; 25(4):279-85. PubMed ID: 14693257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical and psychosocial services in drug abuse treatment: do stronger linkages promote client utilization?
    Friedmann PD; D'Aunno TA; Jin L; Alexander JA
    Health Serv Res; 2000 Jun; 35(2):443-65. PubMed ID: 10857471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical dependency treatment and employment outcomes: results from the 'ADATSA' program in Washington State.
    Luchansky B; Brown M; Longhi D; Stark K; Krupski A
    Drug Alcohol Depend; 2000 Aug; 60(2):151-9. PubMed ID: 10940542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical dependency and psychiatric services for adolescents in private managed care: implications for outcomes.
    Sterling S; Weisner C
    Alcohol Clin Exp Res; 2005 May; 29(5):801-9. PubMed ID: 15897726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Relationship Between Client Characteristics and Wraparound Services in Substance Use Disorder Treatment Centers.
    Paino M; Aletraris L; Roman P
    J Stud Alcohol Drugs; 2016 Jan; 77(1):160-9. PubMed ID: 26751366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Needs of Aboriginal Australian women with comorbid mental and alcohol and other drug use disorders.
    Lee KS; Harrison K; Mills K; Conigrave KM
    Drug Alcohol Rev; 2014 Sep; 33(5):473-81. PubMed ID: 24666748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.